These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15611310)

  • 21. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
    Porter D
    Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
    [No Abstract]   [Full Text] [Related]  

  • 22. Corticosteroids in rheumatoid arthritis.
    Haslock I
    Br J Hosp Med; 1996 Jun 19-Jul 9; 56(1):50. PubMed ID: 8831016
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination cyclosporine and (hydroxy)chloroquine in rheumatoid arthritis.
    Dijkmans BA; Landewé RB; van den Borne BE; Breedveld FC
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S103-4. PubMed ID: 10589367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
    Toki H; Momohara S; Tsukahara S; Ikari K
    J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
    [No Abstract]   [Full Text] [Related]  

  • 25. Is combination second-line therapy in rheumatoid arthritis more aggressive than helpful?
    Berthelot JM; Saraux A; Maugars Y; Prost A; Le Goff P
    Rev Rhum Engl Ed; 1999 Apr; 66(4):224-8. PubMed ID: 10339779
    [No Abstract]   [Full Text] [Related]  

  • 26. The BeSt story: on strategy trials in rheumatoid arthritis.
    Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
    Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
    van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Ewals JA; Han KH; Hazes JM; Kerstens PJ; Peeters AJ; van Zeben D; Breedveld FC; Huizinga TW; Dijkmans BA; Allaart CF
    Arthritis Rheum; 2009 Jan; 61(1):4-12. PubMed ID: 19116965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measures of rheumatoid arthritis disease activity.
    Kirwan J
    J Rheumatol; 2009 Feb; 36(2):442-3; author reply 443-4. PubMed ID: 19208571
    [No Abstract]   [Full Text] [Related]  

  • 29. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
    Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In quest of the holy grail: efficacy versus effectiveness in rheumatoid arthritis.
    Suarez-Almazor ME
    J Rheumatol; 2002 Feb; 29(2):209-11. PubMed ID: 11838836
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
    Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
    Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of a rheumatoid arthritis records-based index of severity.
    Ting G; Schneeweiss S; Katz JN; Weinblatt ME; Cabral D; Scranton RE; Solomon DH
    J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Great expectations of modern RA treatment.
    Irvine S; Capell HC
    Ann Rheum Dis; 2005 Sep; 64(9):1249-51. PubMed ID: 16100338
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of rheumatoid arthritis with ornidazole. A randomized, double-blind, placebo-controlled study.
    Ogrendik M; Hakguder A; Keser N
    Rheumatology (Oxford); 2006 May; 45(5):636-7. PubMed ID: 16436488
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
    Catrina AI; Klareskog L
    Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354
    [No Abstract]   [Full Text] [Related]  

  • 36. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
    Weisman MH
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
    Unübol M; Ayhan M; Guney E
    J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis.
    Radovits BJ; Kievit W; Fransen J; van de Laar MA; Jansen TL; van Riel PL; Laan RF
    Ann Rheum Dis; 2009 Sep; 68(9):1470-3. PubMed ID: 19015210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?
    Huizinga TW; Landewé RB
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):2-3. PubMed ID: 16932617
    [No Abstract]   [Full Text] [Related]  

  • 40. Rheumatoid arthritis: is the disease becoming milder or is treatment improving?
    Walji S; Bykerk VP
    J Rheumatol; 2004 Jun; 31(6):1023-5. PubMed ID: 15170908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.